Abstract. In the present study, mutL homolog 1 (MLH1) small interfering (si)RNA, KU-55933, an ataxia-telangiectasia mutated (ATM) inhibitor, and compound C, an adenosine monophosphate-activated protein kinase (AMPK) inhibitor, were used to investigate the mechanisms underlying temozolomide (TMZ)-induced autophagy and to determine the role of MLH1 and ATM in autophagy. MLH1 siRNA and KU-55933 inhibited the phosphorylation of AMPK and ULK1 and reduced the levels of autophagy. MLH1 siRNA inhibited the phosphorylation of ATM and attenuated TMZ cytotoxicity, whereas the inhibition of ATM-AMPK augmented TMZ cytotoxicity in inherently TMZ-sensitive glioma cells. Therefore, TMZ induced autophagy via the ATM-AMPK pathways and the activation of ATM-AMPK was MLH1-dependent. The inhibition of ATM-AMPK enhanced TMZ cytotoxicity in inherently TMZ-sensitive glioma cells.
Introduction
Previous studies have demonstrated that O 6 -methylguanine DNA methyltransferase (MGMT) can eliminate the temozolomide (TMZ)-induced O 6 -methylguanine (O 6 MeG) DNA adduct and leads to TMZ resistance (1) (2) (3) . However, the MGMT promoter is methylated in almost 50% of glioblastoma specimens and the methylation status of the MGMT promoter in the primary tumor is retained at recurrence (4, 5) . This suggests other mechanisms are involved in TMZ resistance, which remain to be elucidated.
TMZ-induced autophagy functions as a cytoprotective mechanism against TMZ toxicity and contributes to TMZ resistance. The inhibition of autophagy augments TMZ cytotoxicity in glioma (6) (7) (8) . Following nutrient restriction or stress, adenosine monophosphate-activated protein kinase (AMPK) is involved in the formation of the autophagosome by interacting with unc-51-like autophagy activating kinase 1 (ULK1) and induces autophagy (9, 10) . Ataxia-telangiectasia mutated (ATM), a serine/threonine protein kinase, leads to the phosphorylation of AMPK following ionizing radiation or nutrient restriction, which suggests that ATM is the upstream kinase of AMPK (11, 12) . However, the role of ATM-AMPK in TMZ-induced autophagy remains to be elucidated.
DNA mismatch repair (MMR), a genetic repair pathway, is composed of MutS and MutL heterodimers (3, 5) . The O 6 MeG/T mismatches are immediately recognized by MutS (3) and the mutL homolog 1 (MLH1) MMR protein then migrates from the nucleus to the cytoplasm via nuclear export sequences, possibly signaling DNA damage to downstream pathways (13) . However, whether MLH1, a DNA damage messenger, is involved in TMZ-induced autophagy remains to be elucidated.
The present study hypothesized that MLH1 signaled DNA damage to ATM or AMPK and induced autophagy in glioma following treatment with TMZ. To investigate this hypothesis, the activation of AMPK-ULK1 and the levels of autophagy following treatment with MLH1 small interfering (si)RNA and KU-55933 were assessed. The association between MLH1 and ATM was investigated and the effects of the inhibition of autophagy, by knock down of MLH1 and inhibition of ATM-AMPK, on the cytotoxicity of TMZ were evaluated.
Materials and methods
Cell culture and reagents. The U87MG, U251 and SHG-44 glioma cell lines were obtained from the Cell Bank of Chinese Academy of Sciences (Shanghai, China). All cells were plated at a density of 1x10 6 (14) and LC3B, which is cleaved into LC3B-Ⅰ and LC3B-Ⅱ during autophagy, was used as an autophagy marker (15, 16) . Detection of apoptosis. The apoptotic cells were detected using an annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) apoptosis detection kit (cat. no. C1063; Beyotime Institute of Biotechnology, Jiangsu, China) according to the manufacturer's instructions, using flow cytometric analysis on a Guava Easycyte 5HT flow cytometer (EMD Millipore). The data were analyzed using Guava Soft 2.2 software (EMD Millipore).
Detection of the autophagosome/acidic vesicular organelles (AVOs
Cell viability analysis. MTT assays were performed to assess the sensitivity of the cells to the drug treatments. Briefly, the cells were seeded at a density of 3,000 cells/well in 96-well microplates. Following drug treatment, 20 µl MTT (5 mg/ml) was added to each well and the plates were incubated at 37˚C for 4 h. The culture media was subsequently replaced with 100 µl DMSO to lyse the cells, followed by the measurement of absorbance at 570 nm using a Thermo Fisher Scientific Multiskan GO microplate reader (Thermo Fisher Scientific, Inc., Waltham, MA, USA).
Statistical analysis.
All the experiments were performed in triplicate and data are expressed as the mean ± standard deviation. Statistical analysis of the data was performed using Student's t-test for two groups or a one-way analysis of variance for three or more groups. P<0.05 was considered to indicate a statistically significant difference.
Results

TMZ -induced autophagy is MLH1-dependent.
Western blot analysis revealed that TMZ failed to induce the phosphorylation of AMPK or ULK1 following MLH1 knock down in the U87MG, U251 or SHG-44 cells ( Fig. 1A and B) . In the TMZ+MLH1 siRNA group, the cleavage of LC3B was decreased and the number of AVOs was reduced, including under cytotoxic stress, compared with the TMZ group (10.85±1.36%, vs. 34.02±1.77%, respectively; P<0.001). Additionally, the MLH1 siRNA group had fewer AVOs compared with the control group (5.60±0.64%, vs. 12.29±0.91%, respectively; P<0.001; Fig. 1C ), consistent with the LC3B cleavage results (Fig. 1B) . This suggested that MLH1 was important in the activation of TMZ-induced autophagy.
TMZ induces autophagy via pATM, which is MLH1-dependent.
TMZ failed to induce the phosphorylation of AMPK or ULK1 when used in combination with 10 µM KU-55933. The TMZ+KU-55933 group had lower expression levels of LC3B-Ⅰ and LC3B-Ⅱ compared with the TMZ or the control group Fig. 2A) . Consistently, the inhibition of ATM resulted in fewer AVOs in the TMZ+KU-55933 group compared with the TMZ group (9.24±0.38%, vs. 29.90±2.14%, respectively; P<0.001; Fig. 2B ). The levels of LC3B cleavage and AVOs were also reduced in the KU-55933 group compared with the control group ( Fig. 2A and B) . Therefore, TMZ-induced autophagy and the phosphorylation of AMPK were ATM-dependent. Subsequently, the association between MLH1 and ATM was investigated. Compared with the significant phosphorylation of ATM in the TMZ group, the knock down of MLH1 inhibited the phosphorylation of ATM in the MLH1 siRNA and the TMZ+MLH1 siRNA groups (Fig. 2C) , which indicated that the TMZ-induced phosphorylation of ATM was MLH1-dependent.
Knock down of MLH1 leads to TMZ resistance.
Since autophagy is critical for tumor survival, the effect of MLH1 knock down on TMZ cytotoxicity was evaluated. The knock down of MLH1 resulted in a significant decrease in the expression of γH2AX (Fig. 3A) . The knock down of MLH1 also favored U87MG, U251 and SHG-44 cell growth following treatment with TMZ. The MLH1 siRNA and TMZ+MLH1 siRNA groups exhibited normal cell growth, while the cells in the TMZ group exhibited the slowest rate of cell growth (Fig. 3B) . Additionally, the levels of apoptosis in the MLH1 siRNA and TMZ+MLH1 siRNA groups were 5.27±0.67% and 5.74±1.24%, respectively, which were not significantly different compared with the control group (6.25±1.15%), however, levels were lower compared with the TMZ group (14.76±1.59%; Fig. 3C ). This indicated that knock down of MLH1 resulted in TMZ resistance, despite inhibition of autophagy.
ATM inhibition augments TMZ cytotoxicity in inherently TMZ-sensitive glioma cells.
In the TMZ+KU-55933 group, increased expression of γH2AX and reduced cell viability were observed compared with the other groups in the U87MG cells. By contrast, TMZ and KU-55933 had no effect on the expression of γH2AX or on the viability of the U87TMZ cells, suggesting that the inhibition of ATM augmented TMZ cytotoxicity in the inherently TMZ-sensitive cells ( Fig. 3D and E) .
AMPK inhibition disrupts autophagy and augments TMZ cytotoxicity in inherently TMZ-sensitive glioma cells.
The inhibition of AMPK resulted in lower expression levels of LC3B-Ⅰ and LC3B-Ⅱ in the TMZ+compound C group compared with the TMZ group, suggesting that the inhibition of AMPK interrupted TMZ-induced autophagy (Fig. 4A and C) . Since autophagy favors cell survival, the present study investigated whether the inhibition of AMPK augmented TMZ cytotoxicity. As expected, compound C augmented TMZ cytotoxicity, which was indicated by an increase in the expression of γH2AX and in the number of apoptotic cells in the TMZ+compound C group compared with the other groups ( Fig. 4C and D) . The cell viability analysis also revealed that the slowest rate of cell growth was observed in the TMZ+compound C group (Fig. 4B) .
In the U87TMZ cells, the expression levels of pULK1 and LC3B cleavage in the TMZ group were indistinguishable from those in the control group, suggesting that TMZ failed to increase the levels of autophagy in the TMZ-resistant glioma cells. Although compound C decreased LC3B cleavage and reduced cell viability in the compound C and the TMZ+compound C groups, no significant differences were observed in the levels of pULK1, LC3B cleavage or cell viability between these two groups, suggesting that the reduction in autophagy in the U87TMZ cells was not associated with TMZ ( Fig. 4E and F) . These results indicated that a reduction in autophagy using AMPK inhibitors only augmented TMZ cytotoxicity in inherently TMZ-sensitive tumor lines.
Discussion
Following 6-thioguanine or 5-fluorouracil treatment, MLH1 is involved in G2/M cell cycle arrest for damage repair and, at a later stage, in the induction of autophagy for irreparable DNA damage (17) (18) (19) . The present study indicated that MLH1 is also important in TMZ-induced autophagy. AMPK is a conserved sensor of intracellular energy, which is activated in response to low nutrient availability and cellular stresses and is involved in the initiation of autophagosome formation by interacting with the ULK1 autophagy-initiating kinase (9, 10) . Following DNA damage or nutrient restriction, pATM leads to the phosphorylation of AMPK, indicating that ATM is an upstream kinase of AMPK (11, 12) . The results from the present study demonstrated that TMZ-induced AMPK phosphorylation was regulated by ATM. Following ATM inhibition, TMZ failed to induce the phosphorylation of AMPK or ULK1, which led to decreased levels of LC3B cleavage and AVO formation. The activation of AMPK-ULK1 was also under MLH1 regulation, however the association between MLH1 and ATM remained to be determined.
Following the detection of DNA mismatches by MutS, MLH1 is recruited to the foci, undergoes conformational changes through cycles of ATP binding and hydrolysis and recruits and/or activates downstream effector proteins (20) (21) (22) . The present study hypothesized that ATM was a downstream protein of MLH1 and the results supported this hypothesis, as TMZ induced autophagy via the phosphorylation of ATM in an MLH1-dependent manner.
Notably, knock down of MLH1 and inhibition of ATM-AMPK decreased autophagy, however, the opposite effect was observed on TMZ cytotoxicity. TMZ-induced O 6 MeG/T mismatches are firstly bound and recognized by MutS, which subsequently recruits MutL to the foci (21, 23) . The MutS-MutL complex excises the mispaired thymine, while O 6 MeG persists in the template strand (3). Such failed replication cycles with the repeated reinsertion and excision of thymine results in replication fork collapse and DSBs (3). MLH1 is a major component of the MMR pathway and MLH1 deficiency leads to failure of the MMR pathway to recognize the O 6 MeG/T mismatches, leading to TMZ resistance (3, 24, 25) . By contrast, ATM-AMPK had no effect on the failed cell cycles or on the formation of DSB, however, it was involved in autophagy. Therefore, the inhibition of ATM-AMPK decreased autophagy and increased the therapeutic efficacy of TMZ in the inherently TMZ-sensitive cells. Kanzawa et al demonstrated that inhibiting autophagy at an early stage using 3-methyladenine suppresses the characteristic recruitment of LC3 to autophagosome membranes and rescues tumor cells from cell death (26) . Whether MLH1 is involved in the localization of LC3 requires further investigation. The present study demonstrated for the first time, to the best of our knowledge, that TMZ induced autophagy through the ATM-AMPK pathways, which occured in an MLH1-dependent manner. Although the knock down of MLH1 and inhibition of ATM-AMPK decreased TMZ-induced autophagy, MLH1 knock down led to TMZ-resistance in the glioma cells, while ATM-AMPK inhibition augmented TMZ cytotoxicity.
